AAAAAA
Results:
1-7
|
Results: 7
Authors:
Kayhty, H
Ahman, H
Citation: H. Kayhty et H. Ahman, Bridging phase 2 and phase 3 pneumococcal immunologic data for future combination vaccines, CLIN INF D, 33, 2001, pp. S292-S298
Authors:
Wuorimaa, T
Dagan, R
Eskola, J
Janco, J
Ahman, H
Leroy, O
Kayhty, H
Citation: T. Wuorimaa et al., Tolerability and immunogenicity of an eleven-valent pneumococcal conjugatevaccine healthy toddlers, PEDIAT INF, 20(3), 2001, pp. 272-277
Authors:
Nurkka, A
Ahman, H
Korkeila, M
Jantti, V
Kayhty, H
Eskola, J
Citation: A. Nurkka et al., Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine, PEDIAT INF, 20(1), 2001, pp. 25-33
Authors:
Nurkka, A
Ahman, H
Yaich, M
Eskola, J
Kayhty, H
Citation: A. Nurkka et al., Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT, VACCINE, 20(1-2), 2001, pp. 194-201
Authors:
Korkeila, M
Lehtonen, H
Ahman, H
Leroy, O
Eskola, J
Kayhty, H
Citation: M. Korkeila et al., Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid, VACCINE, 18(13), 2000, pp. 1218-1226
Authors:
Ahman, H
Kayhty, H
Vuorela, A
Leroy, O
Eskola, J
Citation: H. Ahman et al., Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid, VACCINE, 17(20-21), 1999, pp. 2726-2732
Authors:
Anttila, M
Eskola, J
Ahman, H
Kayhty, H
Citation: M. Anttila et al., Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood, VACCINE, 17(15-16), 1999, pp. 1970-1977
Risultati:
1-7
|